MeSH definition : A dextroamphetamine drug precursor that also functions as a CENTRAL NERVOUS SYSTEM
STIMULANT and DOPAMINE UPTAKE INHIBITOR and is used in the treatment of ATTENTION
DEFICIT HYPERACTIVITY DISORDER.;
A dextroamphetamine drug precursor that also functions as a CENTRAL NERVOUS SYSTEM
STIMULANT and DOPAMINE UPTAKE INHIBITOR and is used in the treatment of ATTENTION
DEFICIT HYPERACTIVITY DISORDER.
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/portraits-decrivant-les-interventions-pharmacologiques-et-non-pharmacologiques-entourant-le-trouble-du-deficit-de-lattention-avec-ou-sans-hyperactivite-tdah-chez-les-quebecois-de-25-ans-et-moins.html 2017 false false false Canada French practice guideline attention deficit disorder with hyperactivity child adolescent young adult quebec review of literature central nervous system stimulants methylphenidate dextroamphetamine Delayed-Action preparations Lisdexamfetamine Dimesylate Atomoxetine Hydrochloride centrally acting sympathomimetics age factors sex factors drug utilization drug utilization
--- https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/vyvanse-3432.html 2016 false Canada French English Lisdexamfetamine Dimesylate evaluation of the transparency committee attention deficit disorder with hyperactivity child adolescent lisdexamfetamine central nervous system stimulants prodrugs treatment outcome Cost-Benefit analysis adult clinical trials as topic administration, oral drug evaluation
--- Summary Basis of Decision (SBD) VYVANSE - lisdexamfetamine dimesylate https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00311 2010 false Canada French English Lisdexamfetamine Dimesylate drug approval canada attention deficit disorder with hyperactivity prodrugs central nervous system stimulants capsules administration, oral child lisdexamfetamine drug information
--- https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Vyvanse-December-18-2009_f.pdf 2009 false Canada French Lisdexamfetamine Dimesylate Lisdexamfetamine Dimesylate attention deficit disorder with hyperactivity canada insurance, health, reimbursement child randomized controlled trials as topic Cost-Benefit analysis treatment outcome lisdexamfetamine drug evaluation